Using the same siRNA HTS data set as well as subsequent experimental validation in vitro, in vivo, and PAH clinical samples, we identified another novel BMPR2 signaling modifier gene, protein tyrosine phosphatase non-receptor type 1 (PTPN1), with potential relevance to PAH. Here, PTPN1 is linked to pulmonary arterial hypertension.